Nurtec is the first oral calcitonin gene-related peptide antagonist approved for both acute and preventative treatment of migraine.
Mary Beth Seipel, PharmD, BCACP
Advertisement
Articles by Mary Beth Seipel, PharmD, BCACP
Advertisement
Latest Updated Articles
Overview of Nurtec ODT for Prevention of Episodic MigrainePublished: January 4th 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
Regular Melatonin Supplementation May Hide Hidden Heart Complications
3
Early Detection of Type 1 Diabetes: The Power of Screening and Preparation
4
COVID-19 During Pregnancy Raises Neurodevelopmental Risks in Children
5
